sales@intentmarketresearch.com
+1 463-583-2713
As per Intent Market Research, the DNA Forensics Market was valued at USD 2.3 billion in 2023 and will surpass USD 3.8 billion by 2030; growing at a CAGR of 7.3% during 2024 - 2030.
The DNA forensics market is witnessing rapid growth, driven by advancements in genetic technologies, increasing demand for accurate and reliable identification methods, and rising adoption in law enforcement, healthcare, and legal applications. With expanding applications in criminal investigations, paternity testing, and disaster victim identification, DNA forensics has become a critical tool across diverse industries. Technological innovations such as next-generation sequencing (NGS) and automation are further propelling market growth, making DNA forensics faster, more accessible, and increasingly precise.
Criminal investigation remains the largest application segment in the DNA forensics market. The increasing prevalence of violent crimes, sexual assault cases, and property crimes has significantly driven the adoption of DNA forensics as a primary investigative tool. Law enforcement agencies worldwide are leveraging DNA profiling to solve cases, often decades old, by matching crime scene evidence with national or global DNA databases.
Additionally, advancements in rapid DNA testing have enabled law enforcement agencies to identify suspects more quickly and with greater accuracy. The integration of next-generation sequencing (NGS) with criminal investigation protocols is further enhancing the capabilities of forensic teams to process complex samples, such as degraded or mixed DNA evidence.
Among the various types of technologies, Next-Generation Sequencing (NGS) is the fastest-growing segment. NGS offers unparalleled accuracy, scalability, and the ability to process multiple DNA samples simultaneously, making it an ideal solution for complex cases such as disaster victim identification and ancestry analysis.
NGS has revolutionized DNA forensics by enabling high-resolution genomic profiling. Its ability to generate comprehensive genetic information from degraded samples has made it indispensable in solving cold cases and identifying missing persons. As costs for NGS technologies continue to decrease, their adoption is expected to grow significantly across all segments of the DNA forensics market.
Forensic laboratories are the largest end-user segment in the DNA forensics market. These facilities handle a majority of DNA analysis, particularly for criminal investigations and legal cases. Equipped with advanced analytical tools, forensic laboratories process high volumes of samples with stringent accuracy and chain-of-custody protocols.
The growing demand for forensic services from law enforcement agencies and the increasing establishment of centralized and regional laboratories have further bolstered this segment. Laboratories are increasingly adopting automation and robotics to enhance efficiency and throughput, catering to the rising demand for DNA analysis in legal and criminal contexts.
Among sample types, blood is the largest segment, primarily due to its reliability and ease of DNA extraction. Blood samples provide high-quality DNA, enabling accurate identification in applications ranging from criminal investigations to paternity testing and disaster victim identification.
The widespread availability of blood as a sample type in crime scenes, medical tests, and personal identification makes it the most preferred medium for DNA profiling. Technological advancements in extracting and amplifying DNA from blood have further enhanced its utility in forensic applications, ensuring it remains the dominant sample type in the market.
North America is the largest regional market for DNA forensics, owing to its advanced forensic infrastructure, high adoption rates of cutting-edge technologies, and strong government support for forensic programs. Countries such as the United States and Canada have established extensive national DNA databases, significantly aiding law enforcement agencies in solving crimes and identifying missing persons.
The region also benefits from a strong network of forensic laboratories, research institutes, and technological innovators. Investments in next-generation sequencing and rapid DNA analysis are further driving growth, with North America setting benchmarks for other regions to follow.
The DNA forensics market is highly competitive, with key players focusing on innovation, product launches, and strategic partnerships to strengthen their market positions. Companies such as Thermo Fisher Scientific, Promega Corporation, and Qiagen lead the market, offering advanced DNA analysis tools and kits. Emerging players like Verogen and IntegenX are driving innovation with specialized solutions for law enforcement and ancestry testing.
The competitive landscape is marked by continuous advancements in technologies such as NGS and automation, as well as increased focus on cost reduction to make DNA forensics accessible to a broader audience. Collaborations between forensic laboratories and technology providers are expected to play a pivotal role in shaping the future of the market.
Report Features |
Description |
Market Size (2023) |
USD 2.3 Billion |
Forecasted Value (2030) |
USD 3.8 Billion |
CAGR (2024 – 2030) |
7.3% |
Base Year for Estimation |
2023 |
Historic Year |
2022 |
Forecast Period |
2024 – 2030 |
Report Coverage |
Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments |
Segments Covered |
DNA Forensics Market by Application (Criminal Investigation, Paternity Testing, Ancestry Testing, Missing Person Identification, Disaster Victim Identification), Type (Capillary Electrophoresis, Polymerase Chain Reaction, Next-Generation Sequencing, Microarrays), End-User (Law Enforcement Agencies, Forensic Laboratories, Academic and Research Institutes, Healthcare and Clinical Settings, Government and Legal Agencies), Sample Type (Blood, Hair, Saliva, Semen, Bone) |
Regional Analysis |
North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa) |
Major Companies |
Thermo Fisher Scientific, Promega Corporation, Qiagen, Illumina, Inc., Agilent Technologies, GE Healthcare, Bio-Rad Laboratories, F. Hoffmann-La Roche AG, Eurofins Scientific, LGC Limited, NEC Corporation, NMS Labs, Verogen, Inc., Labcorp, IntegenX |
Customization Scope |
Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements |
1. Introduction |
1.1. Market Definition |
1.2. Scope of the Study |
1.3. Research Assumptions |
1.4. Study Limitations |
2. Research Methodology |
2.1. Research Approach |
2.1.1. Top-Down Method |
2.1.2. Bottom-Up Method |
2.1.3. Factor Impact Analysis |
2.2. Insights & Data Collection Process |
2.2.1. Secondary Research |
2.2.2. Primary Research |
2.3. Data Mining Process |
2.3.1. Data Analysis |
2.3.2. Data Validation and Revalidation |
2.3.3. Data Triangulation |
3. Executive Summary |
3.1. Major Markets & Segments |
3.2. Highest Growing Regions and Respective Countries |
3.3. Impact of Growth Drivers & Inhibitors |
3.4. Regulatory Overview by Country |
4. DNA Forensics Market, by Application (Market Size & Forecast: USD Million, 2022 – 2030) |
4.1. Criminal Investigation |
4.2. Paternity Testing |
4.3. Ancestry Testing |
4.4. Missing Person Identification |
4.5. Disaster Victim Identification |
4.6. Others |
5. DNA Forensics Market, by Type (Market Size & Forecast: USD Million, 2022 – 2030) |
5.1. Capillary Electrophoresis (CE) |
5.2. Polymerase Chain Reaction (PCR) |
5.3. Next-Generation Sequencing (NGS) |
5.4. Microarrays |
5.5. Others |
6. DNA Forensics Market, by End-User (Market Size & Forecast: USD Million, 2022 – 2030) |
6.1. Law Enforcement Agencies |
6.2. Forensic Laboratories |
6.3. Academic and Research Institutes |
6.4. Healthcare and Clinical Settings |
6.5. Government and Legal Agencies |
7. DNA Forensics Market, by Sample Type (Market Size & Forecast: USD Million, 2022 – 2030) |
7.1. Blood |
7.2. Hair |
7.3. Saliva |
7.4. Semen |
7.5. Bone |
7.6. Others |
8. Regional Analysis (Market Size & Forecast: USD Million, 2022 – 2030) |
8.1. Regional Overview |
8.2. North America |
8.2.1. Regional Trends & Growth Drivers |
8.2.2. Barriers & Challenges |
8.2.3. Opportunities |
8.2.4. Factor Impact Analysis |
8.2.5. Technology Trends |
8.2.6. North America DNA Forensics Market, by Application |
8.2.7. North America DNA Forensics Market, by Type |
8.2.8. North America DNA Forensics Market, by End-User |
8.2.9. North America DNA Forensics Market, by Sample Type |
8.2.10. By Country |
8.2.10.1. US |
8.2.10.1.1. US DNA Forensics Market, by Application |
8.2.10.1.2. US DNA Forensics Market, by Type |
8.2.10.1.3. US DNA Forensics Market, by End-User |
8.2.10.1.4. US DNA Forensics Market, by Sample Type |
8.2.10.2. Canada |
8.2.10.3. Mexico |
*Similar segmentation will be provided for each region and country |
8.3. Europe |
8.4. Asia-Pacific |
8.5. Latin America |
8.6. Middle East & Africa |
9. Competitive Landscape |
9.1. Overview of the Key Players |
9.2. Competitive Ecosystem |
9.2.1. Level of Fragmentation |
9.2.2. Market Consolidation |
9.2.3. Product Innovation |
9.3. Company Share Analysis |
9.4. Company Benchmarking Matrix |
9.4.1. Strategic Overview |
9.4.2. Product Innovations |
9.5. Start-up Ecosystem |
9.6. Strategic Competitive Insights/ Customer Imperatives |
9.7. ESG Matrix/ Sustainability Matrix |
9.8. Manufacturing Network |
9.8.1. Locations |
9.8.2. Supply Chain and Logistics |
9.8.3. Product Flexibility/Customization |
9.8.4. Digital Transformation and Connectivity |
9.8.5. Environmental and Regulatory Compliance |
9.9. Technology Readiness Level Matrix |
9.10. Technology Maturity Curve |
9.11. Buying Criteria |
10. Company Profiles |
10.1. Thermo Fisher Scientific |
10.1.1. Company Overview |
10.1.2. Company Financials |
10.1.3. Product/Service Portfolio |
10.1.4. Recent Developments |
10.1.5. IMR Analysis |
*Similar information will be provided for other companies |
10.2. Promega Corporation |
10.3. Qiagen |
10.4. Illumina, Inc. |
10.5. Agilent Technologies |
10.6. GE Healthcare |
10.7. Bio-Rad Laboratories |
10.8. F. Hoffmann-La Roche AG |
10.9. Eurofins Scientific |
10.10. LGC Limited |
10.11. NEC Corporation |
10.12. NMS Labs |
10.13. Verogen, Inc. |
10.14. Labcorp |
10.15. IntegenX |
11. Appendix |
A comprehensive market research approach was employed to gather and analyze data on the DNA Forensics Market. In the process, the analysis was also done to analyze the parent market and relevant adjacencies to measure the impact of them on the DNA Forensics Market. The research methodology encompassed both secondary and primary research techniques, ensuring the accuracy and credibility of the findings.
Secondary research involved a thorough review of pertinent industry reports, journals, articles, and publications. Additionally, annual reports, press releases, and investor presentations of industry players were scrutinized to gain insights into their market positioning and strategies.
Primary research involved conducting in-depth interviews with industry experts, stakeholders, and market participants across the DNA Forensics ecosystem. The primary research objectives included:
A combination of top-down and bottom-up approaches was utilized to analyze the overall size of the DNA Forensics Market. These methods were also employed to assess the size of various subsegments within the market. The market size assessment methodology encompassed the following steps:
To ensure the accuracy and reliability of the market size, data triangulation was implemented. This involved cross-referencing data from various sources, including demand and supply side factors, market trends, and expert opinions. Additionally, top-down and bottom-up approaches were employed to validate the market size assessment.